Global Health Matters

Photo credt: GISAID
16 December 2021 - By Thomas B. Cueni
This op-ed was originally published for Swissinfo on 16 December 2021. Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, calls for unrestricted access to pathogen sharing to help the world prepare for new variants and future pandemics. Before the Covid-19 pandemic, only experts knew what ...
Read More
10 December 2021 - By
In this blog, originally published on UHC2030, UHC2030’s Private Sector Constituency shares some examples of how the private sector contributes to strengthening health systems for UHC and health security. At least half the world’s population still lacks access to essential health services, and almost 100 million people are pushed into ...
Read More
9 December 2021 - By James Anderson
This op-ed was originally published for Media Planet Value of Vaccines campaign on 9 December 2021. It is difficult to predict the nature of the next health threat. We do not know where, how or when it will hit. What we know is that playing catch is a lost battle. ...
Read More
1 December 2021 - By Greg Perry
This World AIDS Day, we mark 40 years since the first HIV case was identified. While there is much to reflect on, the most important takeaway is that there is still further to go to prevent new infections and treat the millions of people living with HIV/AIDS today. HIV has ...
Read More
25 November 2021 - By James Anderson
This op-ed was originally published on Pharma Boardroom on 25 November 2021. The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers a unique opportunity to take a look back and share some important lessons learnt ...
Read More
18 November 2021 - By Luka Šrot & Muhammad Ibrahim Khan
Sometimes dubbed the “silent pandemic,” Antimicrobial Resistance (AMR) is a natural phenomenon that occurs when microorganisms such as bacteria adapt after repeated exposure to antibiotics, rendering treatments ineffective. It has been at the top of the global health agenda for many years, and young professionals in healthcare are acutely aware ...
Read More
18 November 2021 - By James Anderson
This op-ed was originally published for Media Planet's AMR Campaign on 18 November 2021. For a long time, the world has recognised the threat posed by antimicrobial resistance (AMR) but the pipeline of new antibiotics to tackle it remains too weak. The WHO has recognised AMR as one of the ...
Read More
18 November 2021 - By Thomas B. Cueni
This op-ed was originally published for Media Planet's AMR Campaign on 18 November 2021. AMR is a silent pandemic that needs attention now. Globally, we need to take action or it will continue to claim lives. It’s been 18 months since the world was struck by the COVID-19 pandemic. Though ...
Read More
15 November 2021 - By Morgane De Pol & Ursula Chauvineau
In December 2020, we witnessed a scientific feat that will go down in history books. This was just 10 months after the WHO declared COVID-19 a pandemic. While many welcomed the news and saw it as the best way to protect themselves and others around them, we knew that, as ...
Read More
For World Diabetes Day on 14 November, Ann-Lise Mikolajczak, Associate Manager, Value and Access and James Anderson, Executive Director of Global Health, sat down to discuss global diabetes care. This Q&A was developed in collaboration with HYPER Network, a platform for young industry professionals.  Ann-Lise: The WHO Global Diabetes Compact ...
Read More
9 November 2021 - By Ann-Lise Mikolajczak
This op-ed was originally published on Foresight Global Health on 8 November 2021. The discovery of insulin in 1921 changed type 1 diabetes from a death sentence to a condition that can be controlled and managed successfully. Yet a hundred years later, children still die from diabetes, especially in low- and ...
Read More
30 September 2021 - By Paula Barbosa
This oped was originally published on Pharma Boardroom on 29 September 2021. Last flu season was exceptionally mild because of the measures used to contain COVID-19, like physical distancing and masks. But what will the upcoming flu season look like? Natural immunity against flu is likely to be lower because of last ...
Read More
27 September 2021 - By Vanessa Peberdy & Ruth Musila
This op-ed was originally published for Media Planet's Neglected Tropical Diseases campaign on 27 September 2021. The global burden of neglected tropical diseases (NTDs) affects over 1.7 billion people living in poverty, predominantly in South America, Africa and Asia. In the past decade, the global health community has made strides ...
Read More
23 September 2021 - By Thomas B. Cueni
This op-ed was originally published for Media Planet's Infectious Diseases campaign on 23 September 2021. With the world’s gaze focused on ramping up production and delivery of 11 billion safe and effective COVID-19 vaccine doses within a year, it is important that we turn an eye to the future. As ...
Read More
16 September 2021 - By Thomas B. Cueni
Last week we convened another media briefing on the biopharmaceutical industry’s efforts to ramp up manufacturing capacity for COVID-19 vaccines, treatments and supplies. We were joined by CEOs and executives from Pfizer, Roche, Merck, Johnson & Johnson, whose 3 main take-aways I would like to share with you. The historic ...
Read More